|
1
|
Global Initiative for Chronic Obstructive
Lung Disease, . Global strategy for the diagnosis, management,
prevention of Chronic Obstructive Pulmonary Disease. 2023.Available
from. http://www.goldcopd.org./
|
|
2
|
Rabe KF and Watz H: Chronic obstructive
pulmonary disease. Lancet. 389:1931–1940. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neder JA, Kirby M, Santyr G, Pourafkari M,
Smyth R, Phillips DB, Crinion S, de-Torres JP and O'Donnell DE:
V̇/Q̇ Mismatch: A novel target for COPD treatment. Chest.
162:1030–1047. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leiby KL, Raredon MSB and Niklason LE:
Bioengineering the Blood-gas Barrier. Compr Physiol. 10:415–452.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weibel ER and Knight BW: A morphometric
study on the thickness of the pulmonary air-blood barrier. J Cell
Biol. 21:367–396. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Falcon-Rodriguez CI, Osornio-Vargas AR,
Sada-Ovalle I and Segura-Medina P: Aeroparticles, composition, and
lung diseases. Front Immunol. 7:32016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao L, Zeng N, Yuan Z, Wang T, Chen L,
Yang D, Xu D, Wan C, Wen F and Shen Y: Knockout of Formyl peptide
Receptor-1 attenuates cigarette smoke-induced airway inflammation
in mice. Front Pharmacol. 12:6322252021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin H, Wang C, Yu H, Liu Y, Tan L, He S,
Li Z, Wang C, Wang F, Li P and Liu J: Protective effect of total
Saponins from American ginseng against cigarette smoke-induced COPD
in mice based on integrated metabolomics and network pharmacology.
Biomed Pharmacother. 149:1128232022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vij N, Chandramani-Shivalingappa P, Van
Westphal C, Hole R and Bodas M: Cigarette smoke-induced autophagy
impairment accelerates lung aging, COPD-emphysema exacerbations and
pathogenesis. Am J Physiol Cell Physiol. 314:C73–C87. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng H, Kong X, Zhang H, Chen Y, Cai S,
Luo H and Chen P: Inhibiting DNA methylation alleviates cigarette
smoke extract-induced dysregulation of Bcl-2 and endothelial
apoptosis. Tob Induc Dis. 18:512020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Eeckhoutte HP, Donovan C, Kim RY,
Conlon TM, Ansari M, Khan H, Jayaraman R, Hansbro NG, Dondelinger
Y, Delanghe T, et al: RIPK1 kinase-dependent inflammation and cell
death contribute to the pathogenesis of COPD. Eur Respir J.
61:22015062023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
D'Anna SE, Maniscalco M, Cappello F,
Carone M, Motta A, Balbi B, Ricciardolo FLM, Caramori G and Stefano
AD: Bacterial and viral infections and related inflammatory
responses in chronic obstructive pulmonary disease. Ann Med.
53:135–150. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suresh A, Rao TC, Solanki S, Suresh MV,
Menon B and Raghavendran K: The holy basil administration
diminishes the NF-kB expression and protects alveolar epithelial
cells from pneumonia infection through interferon gamma. Phytother
Res. 36:1822–1835. 2022. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang B, Li H, Zhang J, Hang Y and Xu Y:
Activating transcription factor 3 protects alveolar epithelial type
II cells from Mycobacterium tuberculosis infection-induced
inflammation. Tuberculosis (Edinb). 135:1022272022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hardy KS, Tuckey AN, Renema P, Patel M,
Al-Mehdi AB, Spadafora D, Schlumpf CA, Barrington RA, Alexeyev MF,
Stevens T, et al: ExoU induces lung endothelial cell damage and
activates pro-inflammatory Caspase-1 during pseudomonas aeruginosa
infection. Toxins (Basel). 14:1522022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv R, Zhao Y, Wang X, He Y, Dong N, Min X,
Liu X, Yu Q, Yuan K, Yue H, et al: GLP-1 analogue liraglutide
attenuates CIH-induced cognitive deficits by inhibiting oxidative
stress, neuroinflammation, and apoptosis via the Nrf2/HO-1 and
MAPK/NF-κB signaling pathways. Int Immunopharmacol. 142:1132222024.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai SY, Liu A, Xie WX, Zhang XQ, Su B, Mao
Y, Weng DG and Chen ZY: Esketamine mitigates mechanical
ventilation-induced lung injury in chronic obstructive pulmonary
disease rats via inhibition of the MAPK/NF-κB signaling pathway and
reduction of oxidative stress. Int Immunopharmacol. 139:1127252024.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang XF, Xiang SY, Lu J, Li Y, Zhao SJ,
Jiang CW, Liu XG, Liu ZB and Zhang J: Electroacupuncture inhibits
IL-17/IL-17R and post-receptor MAPK signaling pathways in a rat
model of chronic obstructive pulmonary disease. Acupunct Med.
39:663–672. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marumo S, Hoshino Y, Kiyokawa H, Tanabe N,
Sato A, Ogawa E, Muro S, Hirai T and Mishima M: p38
mitogen-activated protein kinase determines the susceptibility to
cigarette smoke-induced emphysema in mice. BMC Pulm Med. 14:792014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang JJ, Chen SM, Li HY, Xie QM and Yang
YM: TLR3 inhibitor and tyrosine kinase inhibitor attenuate
cigarette smoke/poly I:C-induced airway inflammation and remodeling
by the EGFR/TLR3/MAPK signaling pathway. Eur J Pharmacol.
890:1736542021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Li SY, Li JS, Deng L, Tian YG, Jiang
SL, Wang Y and Wang YY: A rat model for stable chronic obstructive
pulmonary disease induced by cigarette smoke inhalation and
repetitive bacterial infection. Biol Pharm Bull. 35:1752–1760.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Qin Y, Cai Z, Tian Y, Liu X, Li J
and Zhao P: Effective-components combination improves airway
remodeling in COPD rats by suppressing M2 macrophage polarization
via the inhibition of mTORC2 activity. Phytomedicine.
92:1537592021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin F, Zhang L, Chen K, Miao Y, Liu Y,
Tian Y and Li J: Effective-component compatibility of Bufei Yishen
formula III combined with Electroacupuncture suppresses
inflammatory response in rats with chronic obstructive pulmonary
disease via regulating SIRT1/NF-κB signaling. Biomed Res Int.
2022:33607712022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li MY, Qin YQ, Tian YG, Li KC, Oliver BG,
Liu XF, Zhao P and Li JS: Effective-component compatibility of
Bufei Yishen formula III ameliorated COPD by improving airway
epithelial cell senescence by promoting mitophagy via the
NRF2/PINK1 pathway. BMC Pulm Med. 22:4342022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jia R, Wei M, Zhang X, Du R, Sun W, Wang L
and Song L: Pyroptosis participates in PM2.5-induced
air-blood barrier dysfunction. Environ Sci Pollut Res Int.
29:60987–60997. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yao XH, Luo T, Shi Y, He ZC, Tang R, Zhang
PP, Cai J, Zhou XD, Jiang DP, Fei XC, et al: A cohort autopsy study
defines COVID-19 systemic pathogenesis. Cell Res. 31:836–846. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang
C and Zhang Z: Nanomedicine for acute respiratory distress
syndrome: The latest application, targeting strategy, and rational
design. Acta Pharm Sin B. 11:3060–3091. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matthay MA, Zemans RL, Zimmerman GA, Arabi
YM, Beitler JR, Mercat A, Herridge M, Randolph AG and Calfee CS:
Acute respiratory distress syndrome. Nat Rev Dis Primers. 5:182019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhattacharya J and Matthay MA: Regulation
and repair of the alveolar-capillary barrier in acute lung injury.
Annu Rev Physiol. 75:593–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thompson BT, Chambers RC and Liu KD: Acute
respiratory distress syndrome. N Engl J Med. 377:562–572. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang T, Liu C, Pan LH, Liu Z, Li CL, Lin
JY, He Y, Xiao JY, Wu S, Qin Y, et al: Inhibition of p38 MAPK
mitigates lung ischemia reperfusion injury by reducing Blood-air
barrier Hyperpermeability. Front Pharmacol. 11:5692512020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Viola H, Washington K, Selva C, Grunwell
J, Tirouvanziam R and Takayama S: A High-throughput distal lung
air-blood barrier model enabled by density-driven underside
epithelium seeding. Adv Healthc Mater. 10:e21008792021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mühlfeld C, Neves J, Brandenberger C,
Hegermann J, Wrede C, Altamura S and Muckenthaler MU: Air-blood
barrier thickening and alterations of alveolar epithelial type 2
cells in mouse lungs with disrupted hepcidin/ferroportin regulatory
system. Histochem Cell Biol. 151:217–228. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li W, Long L, Yang X, Tong Z, Southwood M,
King R, Caruso P, Upton PD, Yang P, Bocobo GA, et al: Circulating
BMP9 protects the pulmonary endothelium during inflammation-induced
lung injury in mice. Am J Respir Crit Care Med. 203:1419–1430.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Xue L, Wu Y, Zhang J, Dai Y, Li F,
Kou J and Zhang Y: Ruscogenin attenuates sepsis-induced acute lung
injury and pulmonary endothelial barrier dysfunction via
TLR4/Src/p120-catenin/VE-cadherin signalling pathway. J Pharm
Pharmacol. 73:893–900. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guibourdenche J, Bonnet-Serrano F, Younes
Chaouch L, Sapin V, Tsatsaris V, Combarel D, Laguillier C and
Grange G: Amniotic Aaquaporins (AQP) in normal and pathological
pregnancies: Interest in Polyhydramnios. Reprod Sci. 28:2929–2938.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Weber J, Rajan S, Schremmer C, Chao YK,
Krasteva-Christ G, Kannler M, Yildirim AÖ, Brosien M, Schredelseker
J, Weissmann N, et al: TRPV4 channels are essential for alveolar
epithelial barrier function as protection from lung edema. JCI
Insight. 5:e1344642020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Arroyo R and Kingma PS: Surfactant protein
D and bronchopulmonary dysplasia: A new way to approach an old
problem. Respir Res. 22:1412021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sorensen GL: Surfactant protein D in
respiratory and non-respiratory diseases. Front Med (Lausanne).
5:182018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheung KCP, Fanti S, Mauro C, Wang G, Nair
AS, Fu H, Angeletti S, Spoto S, Fogolari M, Romano F, et al:
Preservation of microvascular barrier function requires CD31
receptor-induced metabolic reprogramming. Nat Commun. 11:35952020.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Akwii RG, Sajib MS, Zahra FT and Mikelis
CM: Role of angiopoietin-2 in vascular physiology and
pathophysiology. Cells. 8:4712019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nicolini G, Forini F, Kusmic C, Iervasi G
and Balzan S: Angiopoietin 2 signal complexity in cardiovascular
disease and cancer. Life Sci. 239:1170802019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dai W, Nadadur RD, Brennan JA, Smith HL,
Shen KM, Gadek M, Laforest B, Wang M, Gemel J, Li Y, et al: ZO-1
regulates intercalated disc composition and atrioventricular node
conduction. Circ Res. 127:e28–e43. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Haas AJ, Zihni C, Krug SM, Maraspini R,
Otani T, Furuse M, Honigmann A, Balda MS and Matter K: ZO-1 guides
tight junction assembly and epithelial morphogenesis via
cytoskeletal tension-dependent and -independent functions. Cells.
11:37752022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kakogiannos N, Ferrari L, Giampietro C,
Scalise AA, Maderna C, Ravà M, Taddei A, Lampugnani MG, Pisati F,
Malinverno M, et al: JAM-A Acts via C/EBP-α to promote claudin-5
expression and enhance endothelial barrier function. Circ Res.
127:1056–1073. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hashimoto Y, Campbell M, Tachibana K,
Okada Y and Kondoh M: Claudin-5: A pharmacological target to modify
the permeability of the blood-brain barrier. Biol Pharm Bull.
44:1380–1390. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Komiya K, Akaba T, Kozaki Y, Kadota JI and
Rubin BK: A systematic review of diagnostic methods to
differentiate acute lung injury/acute respiratory distress syndrome
from cardiogenic pulmonary edema. Crit Care. 21:2282017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Du L, Zhang J, Zhang X, Li C, Wang Q, Meng
G, Kan X, Zhang J and Jia Y: Oxypeucedanin relieves LPS-induced
acute lung injury by inhibiting the inflammation and maintaining
the integrity of the lung air-blood barrier. Aging (Albany NY).
14:6626–6641. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Peng LY, Yuan M, Shi HT, Li JH, Song K,
Huang JN, Yi PF, Fu BD and Shen HQ: Protective effect of
piceatannol against acute lung injury through protecting the
integrity of air-blood barrier and modulating the TLR4/NF-κB
signaling pathway activation. Front Pharmacol. 10:16132020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Peng LY, Shi HT, Yuan M, Li JH, Song K,
Huang JN, Yi PF, Shen HQ and Fu BD: Madecassoside protects against
LPS-induced acute lung injury via inhibiting TLR4/NF-κB activation
and blood-air barrier permeability. Front Pharmacol. 11:8072020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sapoznikov A, Gal Y, Falach R, Sagi I,
Ehrlich S, Lerer E, Makovitzki A, Aloshin A, Kronman C and Sabo T:
Early disruption of the alveolar-capillary barrier in a
ricin-induced ARDS mouse model: Neutrophil-dependent and
-independent impairment of junction proteins. Am J Physiol Lung
Cell Mol Physiol. 316:L255–L268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Uysal P and Uzun H: Relationship between
circulating Serpina3g, Matrix Metalloproteinase-9, and tissue
inhibitor of Metalloproteinase-1 and −2 with chronic obstructive
pulmonary disease severity. Biomolecules. 9:622019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xu K, Ma J, Lu R, Shao X, Zhao Y, Cui L,
Qiu Z, Tian Y and Li J: Effective-compound combination of Bufei
Yishen formula III combined with ER suppress airway mucus
hypersecretion in COPD rats: Via EGFR/MAPK signaling. Biosci Rep.
43:BSR202226692023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rojas DA, Ponce CA, Bustos A, Cortés V,
Olivares D and Vargas SL: Pneumocystis exacerbates inflammation and
mucus hypersecretion in a murine, Elastase-induced-COPD model. J
Fungi (Basel). 9:4522023. View Article : Google Scholar : PubMed/NCBI
|
